MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202523005411 A) filed by Cadila Pharmaceuticals Limited on January 23, 2025, for An Aqueous Parenteral Composition Of Vitamin D3.
Inventors include Bakulesh Mafatlal Khamar; Imran Ahmad Khan; and Mukesh Kanojiya.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: AN AQUEOUS PARENTERAL COMPOSITION OF VITAMIN D3 ABSTRACT The present invention relates to aqueous parenteral composition comprising 300000 to 600000 IU of Vitamin D3, transcutol is 5 to 40% w/v or the mixture of transcutol and glycofurol is 5 to 40% w/v, the surfactant is 5 to 30% w/v and optionally pharmaceutically acceptable excipients, wherein pharmaceutically acceptable excipients selected from derivatives of cyclodextrin.
Disclaimer: Curated by HT Syndication.
